An Italian multicentre study of perampanel in progressive myoclonus epilepsies
暂无分享,去创建一个
P. Striano | R. Michelucci | S. Franceschetti | D. Sebastiano | E. Visani | A. Gambardella | T. Granata | F. Bisulli | M. Fanella | E. Ferlazzo | L. Canafoglia | C. Avolio | U. Aguglia | L. Licchetta | P. Tinuper | A. Magaudda | C. Costa | L. Giuliano | F. Beccaria | F. Zibordi | C. Sueri | C. Bonaventura | E. Freri | F. Ragona | G. d’Orsi | T. Martino | V. Sofia | P. Riguzzi | E. Cesarini | G. Barbella
[1] R. Toledano,et al. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures , 2018, Acta neurologica Scandinavica.
[2] J. García-Peñas,et al. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12‐month GENERAL study , 2018, Epilepsia.
[3] Josemir W Sander,et al. Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data , 2018, Epilepsia.
[4] Wang-Tso Lee,et al. Seizure remission and improvement of neurological function in sialidosis with perampanel therapy , 2018, Epilepsy & Behavior Case Reports.
[5] P. Striano,et al. Variable course of Unverricht-Lundborg disease , 2017, Neurology.
[6] C. Reid,et al. Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K+ channel properties , 2017, Annals of neurology.
[7] A. Crespel,et al. Perampanel in 12 patients with Unverricht‐Lundborg disease , 2017, Epilepsia.
[8] B. Minassian,et al. Efficacy and tolerability of perampanel in ten patients with Lafora disease , 2016, Epilepsy & Behavior.
[9] F. Andermann,et al. Brivaracetam in Unverricht‐Lundborg disease (EPM1): Results from two randomized, double‐blind, placebo‐controlled studies , 2016, Epilepsia.
[10] K. Rijckevorsel,et al. Lafora disease: psychiatric manifestations, cognitive decline, and visual hallucinations , 2015, Acta Neurologica Belgica.
[11] P. Striano,et al. Progressive myoclonic epilepsies , 2014, Neurology.
[12] W. Oertel,et al. Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)☆ , 2013, Epilepsy & Behavior Case Reports.
[13] P. Striano,et al. Neuropsychological findings in patients with Unverricht–Lundborg disease , 2009, Epilepsy & Behavior.
[14] P. Genton,et al. Unverricht‐Lundborg Disease, a Condition with Self‐limited Progression: Long‐term Follow‐up of 20 Patients , 2006, Epilepsia.
[15] M. Hallett,et al. The Unified Myoclonus Rating Scale. , 2002, Advances in neurology.